Literature DB >> 2181153

Transformation of chicken embryo fibroblasts by direct DNA transfection of single oncogenes: comparative analyses of src, erbB, myc, and ras.

M Antczak1, H J Kung.   

Abstract

Chicken embryo fibroblasts (CEF) have been used extensively to study the transformation parameters of a number of avian sarcoma-leukemia viruses. Previously, oncogene transformation of CEF has been conducted almost exclusively with replicating viruses, because of perceived difficulties with direct DNA transfection. Here, we show that CEF can be efficiently and stably transfected by selection for the neomycin resistance gene (neo). Cotransfection of neo with various oncogenes resulted in CEF transformation in vitro and, in several instances, sarcoma formation in vivo. Transfection of src, myc, erbB, and ras, either singly or in combination, resulted in soft-agar colonies with unique morphologies. Transfection of a family of v-src, c-src, and v/c-src chimeric constructs demonstrated the ability of the assay to discriminate between transforming and nontransforming genes. Transfection of a number of erbB variants showed that internal mutations, primarily in the kinase domain, contribute significantly to the ability to transform fibroblasts. The tumorigenic potential detected by transfection of oncogenes faithfully reproduced those previously reported by using viral infections. Our studies establish the utility of CEF transformation by direct DNA transfection. This method should prove useful in analyzing oncogenes, (e.g., myc) that do not readily transform rodent cell lines and in studying host-range mutants of oncogenes, such as those recently identified for src and erbB.

Entities:  

Mesh:

Year:  1990        PMID: 2181153      PMCID: PMC249278          DOI: 10.1128/JVI.64.4.1451-1458.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  AN UNIDENTIFIED VIRUS WHICH CAUSES THE RAPID PRODUCTION OF TUMOURS IN MICE.

Authors:  J J HARVEY
Journal:  Nature       Date:  1964-12-12       Impact factor: 49.962

2.  Disease tropism of c-erbB: effects of carboxyl-terminal tyrosine and internal mutations on tissue-specific transformation.

Authors:  R J Pelley; N J Maihle; C Boerkoel; H K Shu; T H Carter; C Moscovici; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  v-src mutations outside the carboxyl-coding region are not sufficient to fully activate transformation by pp60c-src in NIH 3T3 cells.

Authors:  S Reddy; P Yaciuk; T E Kmiecik; P M Coussens; D Shalloway
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

4.  A novel viral oncogene with structural similarity to phospholipase C.

Authors:  B J Mayer; M Hamaguchi; H Hanafusa
Journal:  Nature       Date:  1988-03-17       Impact factor: 49.962

5.  Interaction with normal cells suppresses the transformed phenotype of v-myc-transformed quail muscle cells.

Authors:  S A La Rocca; M Grossi; G Falcone; S Alemà; F Tatò
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

6.  A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.

Authors:  M F Verderame; J M Kaplan; H E Varmus
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

7.  Massive direct conversion of chick embryo cells by strain MC29 avian leukosis virus.

Authors:  A J Langlois; S Sankaran; P H Hsiung; J W Beard
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

8.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

9.  Linker insertion-deletion mutagenesis of the v-src gene: isolation of host- and temperature-dependent mutants.

Authors:  J E DeClue; G S Martin
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

10.  Proviral-activated c-erbB is leukemogenic but not sarcomagenic: characterization of a replication-competent retrovirus containing the activated c-erbB.

Authors:  R J Pelley; C Moscovici; S Hughes; H J Kung
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

View more
  4 in total

1.  Identification of novel small molecule activators of nuclear factor-κB with neuroprotective action via high-throughput screening.

Authors:  Marina S Manuvakhova; Guyla G Johnson; Misti C White; Subramaniam Ananthan; Melinda Sosa; Clinton Maddox; Sara McKellip; Lynn Rasmussen; Krister Wennerberg; Judith V Hobrath; E Lucile White; Joseph A Maddry; Maurizio Grimaldi
Journal:  J Neurosci Res       Date:  2011-01       Impact factor: 4.164

2.  Tyrosine kinase activity may be necessary but is not sufficient for c-erbB1-mediated tissue-specific tumorigenicity.

Authors:  D C Connolly; S L Toutenhoofd; N J Maihle
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

3.  Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential.

Authors:  H K Shu; R J Pelley; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt.

Authors:  M Aoki; E Blazek; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.